trending Market Intelligence /marketintelligence/en/news-insights/trending/4cdfprfhixc0y-8r9tigva2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Chembio Diagnostics adds director to board


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Chembio Diagnostics adds director to board

Medford, N.Y.-based Chembio Diagnostics Inc., a healthcare supplies company, appointed Mary Polan as director.

Polan is director of Quidel Corp. and Motif BioSciences Inc.

Chembio Diagnostics and its units develop, manufacture and commercialize point-of-care diagnostic tests used to detect or monitor diseases.